2004, Number 3
<< Back Next >>
Acta Med 2004; 2 (3)
Tibolone in hormonal replacement therapy in postmenopausal women
Zárate A, Hernández M, Saucedo R
Language: Spanish
References: 7
Page: 193-195
PDF size: 40.89 Kb.
Text Extraction
No abstract
REFERENCES
— Writing Group for Women´s Health Initiative Investigators. Risks and benefits of estrogen and progestin in healthy postmenopausal women: principal results from the women´s health initiative randomized controlled trial. JAMA 2002; 288: 321-333.
— The Women´s Health Initiative Steering Committee. Effects of conjugated equine estrogen in healthy postmenopausal women with hysterectomy: the Women´s Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1212.
— Modelska K, Cummings S. Tibolone for postmenopausal women: systematic review. J Clin Endocrinol Metab 2002; 87: 16-23.
— Moore RA. Livial: a review of clinical studies. Brit J Obstet Gynec 1999; Supp 19: 1-21.
— Speroff L, Clarkson TB. Is tibolone a viable alternative to HT? Contemporary Ob/Gyn 2003; 48: 54-68.
— Zárate A, Hernández M, Ochoa A, Santos A. Experiencia clínica con tibolona en la terapia de reemplazo hormonal en la postmenopausia. Ginec Obstet Mex 1996; 64: 47-50.
— Saucedo R, Basurto L, Fonseca E, Zárate A. Efecto del reemplazo hormonal con tibolona sobre la insulina plasmática y la glucemia en la postmenopausia. Ginec Obstet Mex 2001; 69: 301-303.
Full text